vs
Side-by-side financial comparison of CSW INDUSTRIALS, INC. (CSW) and LivaNova PLC (LIVN). Click either name above to swap in a different company.
LivaNova PLC is the larger business by last-quarter revenue ($360.9M vs $233.0M, roughly 1.5× CSW INDUSTRIALS, INC.). LivaNova PLC runs the higher net margin — 8.6% vs 4.4%, a 4.2% gap on every dollar of revenue. On growth, CSW INDUSTRIALS, INC. posted the faster year-over-year revenue change (20.3% vs 12.1%). LivaNova PLC produced more free cash flow last quarter ($50.2M vs $22.7M). Over the past eight quarters, LivaNova PLC's revenue compounded faster (10.6% CAGR vs 5.1%).
LivaNova, plc is an American medical device manufacturer based in the UK. The company develops devices used for cardiac surgery and neuromodulation. The company was formed in 2015 by a $2.7B merger between Houston, Texas-based Cyberonics, Inc. and Milan, Italy-based Sorin S.p.a. The company trades on the NASDAQ stock exchange under the ticker symbol "LIVN".
CSW vs LIVN — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $233.0M | $360.9M |
| Net Profit | $10.3M | $30.9M |
| Gross Margin | 39.7% | 65.2% |
| Operating Margin | 7.4% | 11.8% |
| Net Margin | 4.4% | 8.6% |
| Revenue YoY | 20.3% | 12.1% |
| Net Profit YoY | -61.9% | -44.7% |
| EPS (diluted) | $0.62 | $0.57 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $233.0M | $360.9M | ||
| Q3 25 | $277.0M | $357.8M | ||
| Q2 25 | $263.6M | $352.5M | ||
| Q1 25 | $230.5M | $316.9M | ||
| Q4 24 | $193.6M | $321.8M | ||
| Q3 24 | $227.9M | $318.1M | ||
| Q2 24 | $226.2M | $318.6M | ||
| Q1 24 | $210.9M | $294.9M |
| Q4 25 | $10.3M | $30.9M | ||
| Q3 25 | $40.7M | $26.8M | ||
| Q2 25 | $40.9M | $27.2M | ||
| Q1 25 | $35.1M | $-327.3M | ||
| Q4 24 | $26.9M | $55.9M | ||
| Q3 24 | $36.1M | $33.0M | ||
| Q2 24 | $38.6M | $16.3M | ||
| Q1 24 | $31.8M | $-41.9M |
| Q4 25 | 39.7% | 65.2% | ||
| Q3 25 | 43.0% | 68.4% | ||
| Q2 25 | 43.8% | 67.8% | ||
| Q1 25 | 44.2% | 69.7% | ||
| Q4 24 | 41.4% | 68.2% | ||
| Q3 24 | 45.6% | 70.8% | ||
| Q2 24 | 47.5% | 68.7% | ||
| Q1 24 | 44.4% | 70.3% |
| Q4 25 | 7.4% | 11.8% | ||
| Q3 25 | 20.5% | 15.1% | ||
| Q2 25 | 20.8% | 15.4% | ||
| Q1 25 | 19.5% | 15.3% | ||
| Q4 24 | 15.3% | 11.5% | ||
| Q3 24 | 22.6% | 11.2% | ||
| Q2 24 | 24.3% | 12.6% | ||
| Q1 24 | 21.0% | 5.5% |
| Q4 25 | 4.4% | 8.6% | ||
| Q3 25 | 14.7% | 7.5% | ||
| Q2 25 | 15.5% | 7.7% | ||
| Q1 25 | 15.2% | -103.3% | ||
| Q4 24 | 13.9% | 17.4% | ||
| Q3 24 | 15.8% | 10.4% | ||
| Q2 24 | 17.1% | 5.1% | ||
| Q1 24 | 15.1% | -14.2% |
| Q4 25 | $0.62 | $0.57 | ||
| Q3 25 | $2.41 | $0.49 | ||
| Q2 25 | $2.43 | $0.50 | ||
| Q1 25 | $2.05 | $-6.01 | ||
| Q4 24 | $1.60 | $1.04 | ||
| Q3 24 | $2.26 | $0.60 | ||
| Q2 24 | $2.47 | $0.30 | ||
| Q1 24 | $2.03 | $-0.78 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $40.2M | $635.6M |
| Total DebtLower is stronger | — | $376.1M |
| Stockholders' EquityBook value | $1.1B | $1.2B |
| Total Assets | $2.3B | $2.6B |
| Debt / EquityLower = less leverage | — | 0.31× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $40.2M | $635.6M | ||
| Q3 25 | $31.5M | $646.1M | ||
| Q2 25 | $38.0M | $593.6M | ||
| Q1 25 | $225.8M | $738.4M | ||
| Q4 24 | $213.8M | $428.9M | ||
| Q3 24 | $273.2M | $346.4M | ||
| Q2 24 | $18.9M | $329.2M | ||
| Q1 24 | $22.2M | $309.2M |
| Q4 25 | — | $376.1M | ||
| Q3 25 | — | $434.5M | ||
| Q2 25 | — | $430.6M | ||
| Q1 25 | $800.1M | $628.2M | ||
| Q4 24 | — | $627.0M | ||
| Q3 24 | — | $625.5M | ||
| Q2 24 | — | $624.5M | ||
| Q1 24 | $166.0M | $623.8M |
| Q4 25 | $1.1B | $1.2B | ||
| Q3 25 | $1.1B | $1.2B | ||
| Q2 25 | $1.1B | $1.1B | ||
| Q1 25 | $1.1B | $1.0B | ||
| Q4 24 | $1.0B | $1.3B | ||
| Q3 24 | $1.0B | $1.3B | ||
| Q2 24 | $650.2M | $1.2B | ||
| Q1 24 | $615.7M | $1.2B |
| Q4 25 | $2.3B | $2.6B | ||
| Q3 25 | $1.5B | $2.6B | ||
| Q2 25 | $1.5B | $2.5B | ||
| Q1 25 | $1.4B | $2.6B | ||
| Q4 24 | $1.4B | $2.5B | ||
| Q3 24 | $1.4B | $2.5B | ||
| Q2 24 | $1.1B | $2.5B | ||
| Q1 24 | $1.0B | $2.5B |
| Q4 25 | — | 0.31× | ||
| Q3 25 | — | 0.38× | ||
| Q2 25 | — | 0.38× | ||
| Q1 25 | 0.75× | 0.61× | ||
| Q4 24 | — | 0.47× | ||
| Q3 24 | — | 0.48× | ||
| Q2 24 | — | 0.50× | ||
| Q1 24 | 0.27× | 0.51× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.9M | $82.4M |
| Free Cash FlowOCF − Capex | $22.7M | $50.2M |
| FCF MarginFCF / Revenue | 9.8% | 13.9% |
| Capex IntensityCapex / Revenue | 2.6% | 8.9% |
| Cash ConversionOCF / Net Profit | 2.81× | 2.67× |
| TTM Free Cash FlowTrailing 4 quarters | $162.0M | $173.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.9M | $82.4M | ||
| Q3 25 | $61.8M | $85.1M | ||
| Q2 25 | $60.6M | $62.9M | ||
| Q1 25 | $27.3M | $24.0M | ||
| Q4 24 | $11.6M | $78.7M | ||
| Q3 24 | $66.8M | $51.0M | ||
| Q2 24 | $62.7M | $43.4M | ||
| Q1 24 | $22.4M | $10.0M |
| Q4 25 | $22.7M | $50.2M | ||
| Q3 25 | $58.7M | $62.2M | ||
| Q2 25 | $57.7M | $47.8M | ||
| Q1 25 | $22.8M | $13.2M | ||
| Q4 24 | $8.5M | $68.3M | ||
| Q3 24 | $61.3M | $32.8M | ||
| Q2 24 | $59.6M | $31.2M | ||
| Q1 24 | $17.5M | $3.6M |
| Q4 25 | 9.8% | 13.9% | ||
| Q3 25 | 21.2% | 17.4% | ||
| Q2 25 | 21.9% | 13.6% | ||
| Q1 25 | 9.9% | 4.2% | ||
| Q4 24 | 4.4% | 21.2% | ||
| Q3 24 | 26.9% | 10.3% | ||
| Q2 24 | 26.3% | 9.8% | ||
| Q1 24 | 8.3% | 1.2% |
| Q4 25 | 2.6% | 8.9% | ||
| Q3 25 | 1.1% | 6.4% | ||
| Q2 25 | 1.1% | 4.3% | ||
| Q1 25 | 2.0% | 3.4% | ||
| Q4 24 | 1.6% | 3.2% | ||
| Q3 24 | 2.4% | 5.7% | ||
| Q2 24 | 1.4% | 3.8% | ||
| Q1 24 | 2.3% | 2.2% |
| Q4 25 | 2.81× | 2.67× | ||
| Q3 25 | 1.52× | 3.18× | ||
| Q2 25 | 1.48× | 2.32× | ||
| Q1 25 | 0.78× | — | ||
| Q4 24 | 0.43× | 1.41× | ||
| Q3 24 | 1.85× | 1.55× | ||
| Q2 24 | 1.62× | 2.65× | ||
| Q1 24 | 0.71× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CSW
| Contractor Solutions Segment | $166.3M | 71% |
| Specialized Reliability Solutions Segment | $38.2M | 16% |
| Engineered Building Solutions Segment | $28.5M | 12% |
LIVN
| Other | $169.4M | 47% |
| Neuromodulation Segment | $119.7M | 33% |
| Cardiopulmonary Segment | $71.8M | 20% |
